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Both Schistosoma mansoni and Schistosoma haematobium cause schistosomiasis in sub-
Saharan Africa. We assessed the diagnostic value of selected Schistosoma antigens for
the development of a multiplex serological immunoassay for sero-epidemiological
surveillance.
Methodology/Principal Findings
Diagnostic ability of recombinant antigens from S.mansoni and S. haematobium was
assessed by Luminex multiplex immunoassay using plasma from school children in two
areas of Kenya, endemic for different species of schistosomiasis. S.mansoni serine prote-
ase inhibitor (SERPIN) and Sm-RP26 showed significantly higher reactivity to patient
plasma as compared to the control group. Sm-Filamin, Sm-GAPDH, Sm-GST, Sm-LAP1,
Sm-LAP2, Sm-Sm31, Sm-Sm32 and Sm-Tropomyosin did not show difference in reactivity
between S.mansoni infected and uninfected pupils. Sm-RP26 was cross-reactive to
plasma from S. haematobium patients, whereas Sm-SERPIN was species-specific. Sh-
SEPRIN was partially cross-reactive to S.mansoni infected patients. ROC analysis for Sm-
RP26, Sm-SERPIN and Sh-SERPIN showed AUC values of 0.833, 0.888 and 0.947,
respectively. Using Spearman’s rank correlation coefficient analysis, we also found signifi-
cant positive correlation between the number of excreted eggs and median fluorescence
intensity (MFI) from the multiplex immunoassays for Sm-SERPIN (ρ = 0.430, p-value =
0.003) and Sh-SERPIN (ρ = 0.433, p-value = 0.006).
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Conclusions/Significance
Sm-SERPIN is a promising species-specific diagnostic antigen. Sh-SEPRIN was partially
cross-reactive to S.mansoni infected patients. SERPINs showed correlation with the num-
ber of excreted eggs. These indicate prospects for inclusion of SERPINs in the multiplex
serological immunoassay system.
Author Summary
More attention is now shifting towards elimination of some of the neglected tropical dis-
eases, including schistosomiasis. Efficient diagnostics and surveillance tools are the bed-
rock of planning, implementation, monitoring and evaluation of such disease
interventions. We had developed a multiplex immunoassay system for simultaneous
detection of several pathogens in a single limited volume of human sample. To include
Schistosoma antigen among the panel of pathogen antigens, we assessed the diagnostic
value and suitability of selected Schistosoma antigens in multiplex format. S.mansoni ser-
ine protease inhibitor (SERPIN) and Sm-RP26 showed good diagnostic value with signifi-
cant reactivity to patient plasma as compared to the control group. However, S.mansoni
Filamin, GAPDH, GST, LAP1, LAP2, Sm31, Sm32 and Tropomyosin did not show dis-
ease-specific reactivity to plasma from S.mansoni infected patients. While Sm-RP26 was
cross-reactive to plasma from S. haematobium patients, Sm-SERPIN showed species-spe-
cific reactivity. There was also significant positive correlation between the number of
excreted eggs and fluorescence signals from the multiplex immunoassays for the SERPINs.
These findings indicate potentials for utilization of SERPINs in the multiplex system.
Introduction
Globally, more than 240 million people are still infected with schistosomiasis [1]. Over 90% of
the infected people are resident in resource-limited settings in sub-Saharan Africa [2]. The next
target of the current WHO roadmap for the control and elimination of schistosomiasis is to
scale up mass drug administration (MDA) with Praziquantel (PZQ) [3]. Although PZQ is still
efficacious in treating the disease, frequent reinfection necessitates repeated mass chemother-
apy [4]. To achieve elimination, there is need for effective diagnostics to guide planning, imple-
mentation, monitoring and evaluation of the progress of the control intervention [5], and for
surveillance post-elimination. Conventionally, Kato-Katz stool examination is still the gold
standard for the diagnosis. However, this method is now considered relatively less sensitive
than the immunological detection of circulating cathodic antigens (CCA) or circulating anodic
antigens (CAA), for which specificity is still a challenge [6, 7]. Thus, there is need to continue
the search for effective diagnostics with adequate specificity and sensitivity [8]. In addition to
its importance in MDA based interventions, better diagnostics are required for proper assess-
ment of the efficacy of new drugs and vaccines [9].
The distribution of schistosomiasis coincides with several other neglected tropical diseases
(NTDs) and other infectious diseases, including the big three: HIV, malaria and tuberculosis
[10]. Integrating the control activity of these diseases presents a unique opportunity for opti-
mum utilization of the meagre resources for research and health care delivery, especially for
the NTDs whose distributions overlap with poverty [10]. Thus, the need for the development
of novel strategies to simultaneously diagnose these pathogens has been recognized. Such
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strategy will be potentially cost effective and more feasible given the dearth of human resources,
in addition to the requirement for minimal volume of human samples [11].
Our group have been exploring strategies for reliable epidemiological surveillance for infec-
tious diseases, especially the NTDs. In one such approach, we developed a microsphere based
multiplex immunoassay system to simultaneously detect multiple infectious diseases from a
single minimal volume of human sample [12]. This method is ideal in a resource-limited con-
text and is amenable to specific epidemiological settings; depending on the prevalent etiological
agents and epidemiological situations. This strategy is already deployed for screening serotypes
of a single pathogen [13–16], and recently utilized by our team and others for simultaneous
detection of several diseases, including NTDs [12, 17].
For an efficient multiplex detection system, careful selection of antigens to include in the
multiplex immunoassay system is crucial to the efficacy of the product, and indeed is the most
important aspect of the development. For application of this multiplex system in schistosomiasis
endemic areas, we utilized a literature-guided approach to select a panel of 10 Schistosoma man-
soni antigens for assessment and inclusion in the multiplex immunoassay. We identified serine
protease inhibitor (SERPIN) and S.mansoni recombinant protein RP26 as promising candi-
dates. Also, based on assessment of samples from areas of single-species and non-overlapping
transmission of S.mansoni and S. haematobium, we show that SERPIN can be applied to differ-
entially detect the Schistosoma species. The biological role of SERPINs and RP26, and the ratio-
nale and significance of their use for differential diagnosis of Schistosoma species is discussed.
Methods
Ethical considerations
This study was approved by the ethical review committee of Kenya Medical Research Institute,
Kenya (KEMRI, SSC No. 2084) and the ethical review board of Institute of Tropical Medicine,
Nagasaki University, Japan (No. 10121666 and 131219116). Written informed consent was
obtained from parents/guardians and school children prior to the study.
Sources of human plasma and sera
The samples utilized in this study were collected in a cross-sectional study conducted in Mbita
and Kwale areas in Kenya between September 2011 and March 2012. The characteristics of the
population and some initial analyses were detailed in a separate report [18]. Sera from amoebic
liver abscess were obtained from the International Centre for Diarrheal Disease Research, Ban-
gladesh. Diagnoses were confirmed by detection of Entamoeba histolytica-specific DNA in
liver abscess pus specimens. Twenty Leishmania donovani patients’ sera were obtained from
the Rajshahi Medical College in Bangladesh. Again, diagnoses were parasitologically confirmed
by microscopic examination of spleen aspirates. As negative controls, sera from 32 Japanese
individuals were included.
cDNA synthesis
S.mansoni adult worms were stored in RNAlater (QIAGEN) on collection. The samples were
then crushed using Tissue-Ruptor (QIAGEN). Total RNA was isolated from crushed adult
worms using TRIzol plus RNA Purification kit (Ambion), according to the manufacturer’s
instructions. The cDNAs of target regions were amplified by using PrimeScript High Fidelity
RT-PCR Kit (Takara), according to the manufacturer’s instructions. Briefly, the first strand
cDNA was synthesized from RNA with reverse transcriptase using oligo dT primer, and PCR
was performed by using the reverse transcription reaction mixture as the template with a pair
Multiplex Serological Assay for Schistosomiasis
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of specific primers for each candidate antigen. PCR products were purified using QIAEX II Gel
Extraction Kit (QIAGEN). Sh-SERPIN cDNA was chemically synthesized by Integrated DNA
Technologies, Inc. Introduction of G444A mutation in Sm-SERPIN was performed by overlap
extension PCR. The cDNAs were then sub-cloned into pET-52b(+) vector (Novagen). Struc-
ture of the antigens and the fusion tags are summarized in Table 1.
Protein expression and purification
Recombinant antigens were expressed and purified as previously described [12]. GAPDH and
Tropomyosin was located in inclusion body, whereas the other antigens were located in soluble
fraction. S.mansoni soluble egg antigen (SEA) was prepared using standard methods and as
previously detailed [19].
Multiplex assay
Two antigen-coupling protocols were used in this study. For the initial experiments on S.man-
soni antigens, protocol previously reported by our group was used (panel #1) [12]. Briefly, for
1.25 million MagPlex microspheres, 100μg of each antigen (except Tropomyosin) were added.
Because microspheres aggregation was observed for Tropomyosin at 100μg antigen, 0.3μg of
Tropomyosin was added as determined by titration experiment.
Because new protocol was released from Luminex before the subsequent experiment, the
new protocol was used for the second experiment with RP26, Sm-SERPIN and Sh-SERPIN
(panel #2). Binding reaction of antigen on microspheres was performed in coupling buffer
(50mMMES pH 5.0) instead of PBS(-). The amount of antigens in the reaction was reduced to
25μg for 1.25 million microspheres.
Table 1. Structure of the antigens used in this study.
Antigen N-terminus Fusion tag Coding
Region
C-terminus Fusion tag Accession MW
(kDa)*
S. mansoni Cathepsin B
(Sm31)




GAPDH MASWSHPQFEKGALEVLFQGPGYQ 1–338 ELALVPRGSSAHHHHHHHHHH P20287 41.5
GST (Sm28) MASWSHPQFEKGALEVLFQGPGYQDP 1–211 AAAELALVPRGSSAHHHHHHHHHH P09792 29.4
LAP-1 MASWSHPQFEKGALEVLFQGPGYQ 1–523 ELALVPRGSSAHHHHHHHHHH ACQ77148 61.9
LAP-2 MASWSHPQFEKGALEVLFQGPGYQ 1–544 ELALVPRGSSAHHHHHHHHHH ACQ77149 64.9
Legumain
(Sm32)
MASWSHPQFEKGALEVLFQGPGYQDP 1–429 VDAAAELALVPRGSSAHHHHHHHHHH P09841 54.8
RP26 (Sm22.3) MASWSHPQFEKGALEVLFQGPGYQ 20–196 ELALVPRGSSAHHHHHHHHHH AAB81008 25.3
SERPIN MASWSHPQFEKGALEVLFQGPGYQDP 1–406 VDAAAELALVPRGSSAHHHHHHHHHH CCD60071 51.8
Tropomyosin-2 MASWSHPQFEKGALEVLFQGPGYQDP 1–284 VDAAAELALVPRGSSAHHHHHHHHHH P42638 38.5
S.
haematobium
SERPIN MASWSHPQFEKGALEVLFQGPGYQDP 1–406 VDAAAELALVPRGSSAHHHHHHHHHH AAA19730 51.6
The cDNAs containing the coding regions of the antigens were cloned into pET52b expression vector with StrepTagII fusion tag at N-terminus and
polyhistidine tag at C-terminus.
*Predicted molecular weight
doi:10.1371/journal.pntd.0004021.t001
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Statistics
Data analyses were performed on GraphPad Prism version 6.0. Receiver operating characteris-
tics (ROC) analysis was performed to assess diagnostic value of antigens. Mann-Whitney tests
were performed for comparison between two groups. Spearman’s rank correlation coefficient
analysis was performed to assess correlation between two measured variables. Data was pre-
sented as dot plots, with lines and error bars showing the median and interquartile ranges. Sta-
tistical significance was set at p< 0.05.
Results
Preparation and purification of candidate antigens
Previously, we developed a microsphere based multiplex immunoassay system to simulta-
neously detect multiple infectious diseases from a single human sample [12]. To include schis-
tosomiasis in the range of antigens in our multiplex system, we used literature-guided
approach to select 10 Schistosoma mansoni antigens for evaluation and potential inclusion in
the multiplex system. Cathepsin B (Sm31) [20], Filamin [21], Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) [22], Glutathione S-transferase (GST) [23], Legumain (Sm32, Hae-
moglobinase) [20], RP26 (Sm22.3, LGG) [24], Tropomyosin-2 (TM-2) [25] were selected from
reports on S.mansoni diagnosis. Serine protease inhibitor (Sm-SERPIN) was selected from
report on S. haematobium diagnosis [26]. Leucine aminopeptidase-1 (LAP-1) [27] and Leucine
aminopeptidase-2 (LAP-2) were selected from reports on S. japonicum diagnosis [27]. S. hae-
matobium SERPIN was also included for comparison with Sm-SERPIN. Soluble egg antigen
(SEA) from S.mansoni was used as control. Table 1 shows the selected antigens, their GenBank
accession numbers, the N- and C-terminus fusion tags, and predicted molecular weights. The
purified proteins were subjected to SDS-PAGE and protein bands of expected molecular weight
were identified (Fig 1A).
Introduction of point mutation in Sm-SERPIN cDNA
Although protein bands of expected molecular weight was identified for both Sm-SERPIN and
Sh-SERPIN, we observed additional shorter fragment of about 30 kD on Sm-SERPIN lane (Fig
1A). Sequence analysis showed that this shorter fragment was a product of transcription from
prokaryotic start codon (GUG) located at nucleotide 442 in the reference sequence (GenBank:
CCD60071). Therefore, to compare diagnostic ability with similar quality of Sm-SERPIN and
Sh-SERPIN, we introduced a point mutation at nucleotide 444 of the cDNA sequence
(G444A), resulting in codon change from the prokaryotic start codon GUG to GUA. This is a
silent mutation encoding for Valine. This strategy effectively reduced this extra 30 kD fragment
to the minimum in Sm-SERPIN with G444A mutation (Fig 1B). The Sm-SERPIN G444A vari-
ant was therefore used in the subsequent experiments.
Confirmation of antigen coupling
To confirm success of antigen coupling to the MagPlex microsphere beads, phycoerythrin-con-
jugated antibody against the poly-histidine tag was used to determine the number of antigens
on the microspheres. In the initial coupling beads set (Panel #1), all the antigens showed signif-
icantly high signals, indicating success of antigen coupling (Fig 2A). Relatively, SERPIN
showed the highest level of success in antigen coupling (MFI = 8,805), while LAP-1 and RP26
showed the lowest level with MFIs of 1,523 and 1,629, respectively (Fig 2A). In the second cou-
pling beads set (Panel #2), the antigens showed similar MFI values using different coupling
protocol from that used for Panel #1 (Fig 2B).
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Reactivity of Schistosoma mansoni antigens in multiplex assay
The choice of antigens is crucial for the success of the multiplex assay development. To assess
the 10 selected antigens for suitability for diagnosis of schistosomiasis in the multiplex assay, we
compared the reactivity of the S.mansoni candidate antigens in multiplex format against plasma
from pupils resident in two epidemiologically distinct endemic areas in Kenya. While Mbita
area is endemic for S.mansoni, Kwale area is an S. haematobium endemic area. For this initial
screening, twenty-six (26) plasma samples each from well characterized healthy and schistoso-
miasis patients from each endemic area were included in the assays and analyses. Sera from
healthy Japanese volunteers were also included as negative controls from non-endemic area.
Only RP26 and Sm-SERPIN were specifically reactive to plasma from S.mansoni patients
(Fig 3). The other antigens did not show disease-specific reactivity, although the reactivity to
plasma from endemic areas is higher than reactivity to Japanese control as would be expected.
The two antigens with disease-specific reactivity (Sm-RP26 and Sm-SERPIN) showed fluores-
cence signals (MFI) that are similar or higher than signals recorded from evaluation of cou-
pling with anti-polyhistidine-tag antibody (Fig 2A). This further shows that the absence of
reactivity from the other 8 antigens was not a function of number of coupled antigens. For
instance, Sm-RP26 antigen with relatively low microsphere-coupled antigens based on evalua-
tion with anti-polyhistidine-tag antibody showed significant disease-specific reactivity. Inter-
estingly, Sm-RP26 was also reactive to plasma from S. haematobium patients (Fig 3). Our data
Fig 1. The expression and purification of selected antigens. A) SDS-PAGE of antigens for panel #1. The 10 selected antigens were expressed, purified
and analysed using SDS-PAGE. B) SDS-PAGE of Sm-SERPIN G444A. For Sm-SERPIN, an unexpected shorter fragment due to transcription from
prokaryotic start codon (GUG) located at nucleotide 442 was eliminated by introduction of a point mutation at nucleotide 444 of the cDNA sequence (G444A).
C) SDS-PAGE of Sh-SERPIN. Sh-SERPIN was also expressed to assess species-specific identification of schistosomes by SERPINs. GST: Glutathione S-
transferase, RP26: recombinant protein 26 (Sm22.3), TM-2: Tropomyosin-2, SERPIN: serine protease inhibitor, Sm31: Cathepsin-B, Sm32: Legumain, LAP-
1: Leucine aminopeptidase-1, LAP-2: Leucine aminopeptidase-2, GAPDH: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
doi:10.1371/journal.pntd.0004021.g001
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also showed that Sm-SERPIN was efficient in species-specific differential detection of infec-
tions with S.mansoni. Also, S. haematobium SERPIN was previously reported to be species-
specific [26]. The crude egg antigen (SEA) from S.mansoni showed similar MFI value between
egg negative and positive in Mbita area, where S.mansoni is endemic; suggesting that some egg
negative individuals may have history of previous infections. Surprisingly, SEA from S.man-
soni showed disease-specific detection only for S. haematobium patients (Fig 3). Taken
together, our data showed that Sm-SERPIN and Sm-RP26 are promising diagnostic candidates
to be potentially included in our multiplex system. In addition, Sm-SERPIN demonstrated spe-
cies-specific reactivity.
Further characterization of the reactivity of Sm-RP26, Sm-SERPIN and
Sh-SERPIN
To further confirm the diagnostic efficacy of Sm-SERPIN and Sm-RP26 from the preceding
section, we assessed a larger number of plasma for reactivity with the antigens, Sm-RP26 and
Sm-SERPIN. In addition, Sh-SERPIN was included in the analysis to corroborate the species-
specific diagnostic efficacy of SERPINs. Sequence homology of amino acid for the two SER-
PINs is presented in Fig 4. Two sequences are very similar having 76% identical amino acids.
Equally, to preclude the possibility of cross reactivity with other helminths and infectious dis-
eases, plasma from hookworm patients in Kwale area of Kenya, amoebic liver abscess (ALA)
and visceral leishmaniasis (VL) patients in Bangladesh were included in the assays and analy-
ses. Again, similar to data presented in Fig 3, Sm-RP26 was only reactive to plasma from
Fig 2. Confirmation of the efficacy of coupling of S.mansoni antigens on MagPlex microspheres. The efficacy of the coupling process for panel #1 (A)
was confirmed by detection of antibodies against the poly-histidine tag on each antigen using anti-his antibody. The real measured MFI values are shown on
top of bars. (B) The efficacy of the coupling process for panel #2, including RP26 and SERPINs.
doi:10.1371/journal.pntd.0004021.g002
Multiplex Serological Assay for Schistosomiasis
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Fig 3. Reactivity of Schistosomamansoni recombinant antigens in the multiplex immunoassay.Multiplex assays were performed using samples from
S.mansoni (Mbita) and S. haematobium (Kwale) endemic areas, respectively. Negative control samples from each location were included as comparator for
the diagnostic efficacy of each antigen for the two species of schistosomes. The bar lines represent the median while the error bars represent the interquartile
range. Antigens used in this assay: (A) Filamin; (B) GAPDH; (C) GST; (D) LAP-1; (E) LAP-2; (F) RP26; (G) Sm-SERPIN; (H) Sm31; (I) Sm32; (J)
Tropomyosin-2; (K) SEA. Statistical significance was set at p < 0.05 as depicted using asterisks: * = p < 0.05, ** = p < 0.01, *** = p < 0.001, and **** =
p < 0.0001. Jpn: healthy Japanese (n = 7), Sm-: egg negative in Sm endemic area (n = 26), Sm+: S.mansoni egg positive (n = 26), Sh-: egg negative in Sh
endemic area (n = 26), Sh+: S. haematobium egg positive (n = 26).
doi:10.1371/journal.pntd.0004021.g003
Multiplex Serological Assay for Schistosomiasis
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patients with either S.mansoni or S. haematobium (Fig 5A), while Sm-SERPIN was species-
specific (Fig 5B). Sh-SERPIN was partially cross-reactive to plasma from patients with S.man-
soni; with median of MFI value higher in S. haematobium than in S.mansoni (Fig 5C). It was
also noteworthy that cross-reaction was not observed with plasma from ALA, VL and hook-
worm patients (Fig 5). Our observations further provide evidence for the utility of both Sm-
RP26 and SERPINs as good diagnostic antigens for schistosomiasis, in addition to the species-
specific diagnostic advantage of the Sm-SERPIN.
Validation of diagnostic performance of Sm-RP26, Sm-SERPIN and Sh-
SERPIN
We performed ROC analysis for further evaluation of the diagnostic performance of the SER-
PINs and Sm-RP26 in the multiplex assay. Sensitivity and specificity were calculated at MFI
value giving maximum sensitivity plus specificity. For the ROC analysis for Sm-RP26, egg neg-
ative and positive individuals in both Mbita and Kwale were included in the analysis. For SER-
PINs however, data from plasma samples from the endemic area for each species were used.
The ROC curve and the corresponding statistics are summarized in Fig 6. The AUC values for
Sm-SERPIN (0.888) and Sh-SERPIN (0.947) were higher than AUC value for Sm-RP26
(0.833). The two SERPINs recorded sensitivity of approximately or over 90% (92.5% for Sh-
SERPIN and 89.4% for Sm-SERPIN), while Sm-RP26 showed lower sensitivity of 67.8%. Sh-
SERPIN was the most specific antigen with 90% specificity, followed by Sm-RP26 and Sm-SER-
PIN with specificities of 89.5% and 81.5%, respectively (Fig 6). Succinctly, our data indicate
that the SERPINs recorded acceptable levels of sensitivity and specificity and are suitable for
inclusion as diagnostic antigens in the multiplex system. The additional advantage of species-
specific detection also provides further utility for these antigens.
Correlation between number of excreted eggs and fluorescent intensity
of the multiplex immunoassay
The three promising diagnostic antigens from this study will be more valuable if they can also,
in addition to qualitative diagnosis, provide an estimate of the number of excreted eggs. Such
information will be very useful in planning interventions and for prioritization of intervention
to the high-risk populations. Spearman’s rank correlation coefficient was applied for identifica-
tion of correlation between MFI signals from multiplex immunoassays and the number of
Fig 4. Sequence homology of amino acid for SERPINs.Dot shows homologous amino acid.
doi:10.1371/journal.pntd.0004021.g004
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Fig 5. Species-specific differential detection by SERPINs. To demonstrate the species-specific
diagnostic value of the SERPINS, multiplex immunoassay was performed using samples from S.mansoni
(Mbita) and S. haematobium (Kwale) endemic areas, respectively. In addition, amoebic liver abscess
samples, visceral leishmaniasis positive samples and hookworm positive samples were included as controls.
Negative control samples from uninfected individuals from each location were also included. The bar lines
represent the median while the error bars represent the interquartile range. Antigens used in this assay: (A)
Sm-RP26; (B) Sm-SERPIN G444A; (C) Sh-SERPIN. Statistical significance was set at p < 0.05 as depicted
Multiplex Serological Assay for Schistosomiasis
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excreted eggs from subjects (Fig 7). The Spearman’s rank correlation coefficient showed that the
multiplex assay for Sm-SERPIN and Sh-SERPIN had a statistically significant correlation to
average number of observed eggs (for Sm-SERPIN, ρ (rho) = 0.430, p-value = 0.003; for Sh-SER-
PIN, ρ = 0.433, p-value = 0.006). Although Sm-RP26 could detect both species in the earlier
described immunoassays, it only showed slight correlation with only S.mansoni egg number (ρ
= 0.307, p-value = 0.036), but not for S. haematobium (ρ = 0.060, p-value = 0.713). Taken
together, these data indicate the diagnostic potentials of Sm-SERPIN and Sh-SERPIN for
respective species, and strongly support their inclusion in the multiplex immunoassay system.
Discussion
TheWorld Health Organization and schistosomiasis researchers have finally made the decision
to move from morbidity control to attempt elimination when feasible. Driven by the success of
mobilization and donation of PZQ by pharmaceutical companies, the World Health Assembly
(WHA) in its most recent resolution (WHA 65.21 of 2012) have provided fresh impetus and
political will towards the elimination of schistosomiasis [5, 28]. The major tool for this elimina-
tion attempt is MDA using PZQ. This “single-pronged” approach is very worrisome due to the
using asterisks: * = p < 0.05, ** = p < 0.01, *** = p < 0.001, and **** = p < 0.0001. Jpn: healthy Japanese
(n = 32), ALA: amoebic liver abscesses (n = 20), VL: visceral leishmaniasis (n = 20), Hw: Hookworm positive
in Kwale (n = 41), Sm-: egg negative in Sm endemic area (n = 27), Sm+: S.mansoni egg positive (n = 47), Sh-
: egg negative in Sh endemic area (n = 30), Sh+: S. haematobium egg positive (n = 40).
doi:10.1371/journal.pntd.0004021.g005
Fig 6. ROC analysis for RP26, Sm-SERPIN, and Sh-SERPIN. ROC analysis was performed to determine the area under the curve (AUC), sensitivity and
specificity as indicators of the diagnostic value of the SERPINs and RP26. The SERPINs showed relatively better diagnostic ability than RP26.
doi:10.1371/journal.pntd.0004021.g006
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risk of emergence of schistosomes with sub-optimal response to PZQ [4, 28]. This makes it
imperative that the MDA programme is carefully planned, implemented, monitored and evalu-
ated, with effective diagnosis as the mainstay of this approach. Effective diagnosis is required
for disease mapping, an imperative for schistosomiasis MDA implementation [29]. There is
also need for sufficiently sensitive and specific diagnostics for monitoring progress of the inter-
vention and for disease surveillance post- elimination [5, 30]. The Kato-Katz stool examination
is still the gold standard due to its high specificity, although less sensitive [6]. Alternative less
cumbersome methods have been proposed; especially the point-of care circulating cathodic
antigen (POC-CCA) [31, 32]. This method has shown significantly improved sensitivity, albeit
with low specificity [7, 9] relative to Kato-Katz. This situation has even led to arguments for
combination of methods [8], which further emphasizes the need for continued search for a
diagnostics with the desired levels of sensitivity and specificity.
Because several other NTDs and other tropical infectious diseases can also be controlled
using the MDA approach, the integration of their control or elimination has become the pre-
ferred approach [10]. This is particularly relevant given the limited human and material
resources for health intervention in the affected populations. This led us to apply the novel
Fig 7. Correlation analysis of the MFI values from immunoassays and egg number. Spearman’s rank correlation coefficient between observed egg
number and MFI values were calculated for each antigen. (A) Sm egg positive subjects and (B) Sh egg positive subjects. While the antigens showed poor
quantitative correlation with egg number, the SERPINs showed relatively better correlation with egg number than RP26.
doi:10.1371/journal.pntd.0004021.g007
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multiplex technology for simultaneous diagnosis of several diseases, reducing the requirement
for manpower for single-disease approach and the cost of disease-specific diagnostic kits [12].
The multiplex approach is also amenable for embedding into the health system in developing
countries as it can be designed to be site-specific, depending on the prevalent pathogens in
each locality. Here, in order to select an appropriate Schistosoma antigen for inclusion in the
multiplex immunoassay, we assessed a set of previously identified diagnostic antigens. We
found that Sm-RP26 and SERPINs are suitable for inclusion in this multi-pathogen surveil-
lance tool. The SERPIN antigens showed sensitivity levels higher than the gold standard, with
specificity levels comparable to that of the widely successful POC-CCA [7, 32, 33].
We further found that Sm-SERPIN was able to effectively differentiate species of the para-
site. Unexpectedly, our results showed cross-reactivity of Sh-SERPIN to S.mansoni infected
patients, although reactivity was higher to S. haematobium infected patients than to S.mansoni.
In multiplex assay, because both SERPINs can be included in same assay panel, species-specific
Sm-SERPIN will point S.mansoni infected patients out in endemic area of single species. But
this cross-reactivity will be problem for surveillance in area where both strains are endemic.
One of possible approach to get better specificity by SERPINs is finding species-specific epitope
in SERPINs. The species-specific epitope will be located in unique sequence of each of the SER-
PINs (Fig 4). We are presently working towards this direction. This species-specific character-
istic is advantageous for planning surveys and post-elimination surveillance, in addition to its
utility during drug and vaccine development and for planning other non-chemotherapy based
interventions [34].
Another significant challenge in schistosomiasis diagnosis is the absence of a true quantita-
tive gold standard with correlation with actual egg burden, apart from Kato-Katz [9]. In this
study, we found correlation between the multiplex immunoassay MFI signals and the number
of excreted eggs. The MFI is a quantitative unit that lends itself to optimization for quantitative
assessment of disease burden, although further extensive studies are still required to establish
the utility of these antigens in quantitative assessment of disease burden.
The immunodiagnostic potentials of the SERPINs stems from the important physiological
roles they play in schistosomes-host interactions [35, 36]. Furthermore, the presence of multi-
ple copies of the gene encoding Schistosoma SERPIN emphasizes its essential role in parasite
adaptation in the host milieu [37]. SERPINs have been shown to be highly immunogenic,
showing strong reactivity to sera from infected rat [35], sera from rabbit vaccinated with UV-
attenuated schistosomula [38], and sera from a naturally resistant host,Microtus fortis [39].
The unusually low immunogenicity of helminths serine proteases is attributed to their tight
interaction with SERPINs [40]. SERPINs bind tightly and form complexes with otherwise
immunologically active proteases, rendering them immunologically inert [40, 41]. These
molecular interactions form the basis of SERPINs immunomodulatory and immune evasion
roles in the host-parasite interaction [35, 41, 42]. Schistosoma SERPINs are expressed in all
stages of the parasite [35] as secreted or tegument localized proteins [43]. This localization at
the host-parasite interface and inhibitory interaction with host immune effector proteases fur-
ther explain the immunogenicity, immunomodulatory and immune-evasion roles of schisto-
somes SERPINs.
We also identified the Schistosoma recombinant protein RP26 (Sm22.3) as a promising
diagnostic candidate for inclusion in the multiplex immunoassay. The fact that this antigen is
able to detect both species of schistosomes may be useful and cost-effective when considered
from the point of view of diagnosing all species of schistosomes using one kit [44]. RP26 has
also been shown to be valuable in identifying acute infections [24, 45]. Indeed, RP26 is
expressed at the cercarial, schistosomula and immature adult stages of the parasite, and not in
the egg stage [45]. It was found that mean IgG reactivity to RP26 was significantly higher
Multiplex Serological Assay for Schistosomiasis
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during acute schistosomiasis, compared to the negative reaction to sera from chronic infection
[24, 45]. This suggests that the RP26 antigen is mainly exposed to the host immune response at
the acute stage of the infection. This is an interesting phenomenon because IgG response
against most parasite antigens requires longer time to develop and rarely manifests at the early
stage of the infection, relative to other isotypes [46, 47]. This will be particularly useful in moni-
toring progress of interventions by detecting new infections.
In summary, a set of previously published promising diagnostic antigens of S.mansoni were
evaluated for suitability for inclusion in our multiplex disease surveillance system. Out of 10
selected antigens, Sm-SERPIN and Sm-RP26 showed significantly high reactivity to sera from
schistosomiasis patients and good diagnostic potential. While Sm-RP26 could diagnose both
species of the parasites endemic in the study areas, Sm-SERPIN was species-specific. Sh-SER-
PIN was partially cross-reactive to S.mansoni infected patients. The advantage of species-spe-
cific diagnosis by Sm-SERPIN and its potential diagnostic application in a multiplex format is
described taking into account its role in several physiological processes. Sm-RP26 detection of
both species is discussed in terms of its previously reported ability to specifically detect acute
infection, and its potential utility in monitoring progress of intervention and post-elimination
surveillance.
Accession number for proteins
GeneBank accession number for each antigen were as follows; Cathepsin B(Sm31): AAA29865,
Filamin: CCD59036, GAPDH: P20287, GST (Sm28): P09792, LAP-1: ACQ77148, LAP-2:
ACQ77149, Legumain (Sm32): P09841, RP26 (Sm22.3): AAB81008, Sm-Serpin: CCD60071,
Tropomyosin-2: P42638, Sh-Serpin: AAA19730.
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